June 30, 2008


Drug Approvals, Recalls, Adverse Events Update


IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). Recent alerts have included:

IDSA members can sign up for these services online. (You must be logged in to have access to this link.)

How useful is this article?
< Previous Article | Next Article >

Updated Blastomycosis Guidelines Feature New Treatments
New Pre-pandemic Vaccine Highlights Progress, Raises Questions
IDSA Journal Club, June 2008
In the IDSA Journals
Drug Approvals, Recalls, Adverse Events Update
EIN: What to Do About Hepatitis B Vaccine Non-responders
NIAID Solicits Clinical Trials Proposals to Reduce the Risk of Antimicrobial Resistance
New Coding Resource Helps Clinicians Choose Appropriate Service Codes
CMS Releases Problematic New List of Hospital-acquired Conditions
FDA Moves to Update Antibacterial Breakpoints
IDSA Advocacy Update: IDSA Opposes HHS Proposal for Home Stockpiling of Doxycycline
New Book Addresses Questions about Vaccine Safety
New Desktop Software for Keeping Kids on Track with Immunizations
IDSA Holds First Fellows’ In-Training Exam
Members on the Move
Welcome, New IDSA Members!


Search Back Issues
Forward this Issue
Print-Friendly Version

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA